Advisor Partners’s United Therapeutics UTHR Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q2 | $323K | Buy |
1,369
+110
| +9% | +$26K | 0.02% | 612 |
|
|
2022
Q1 | $226K | Buy |
1,259
+10
| +0.8% | +$1.8K | 0.01% | 775 |
|
|
2021
Q4 | $270K | Buy |
1,249
+53
| +4% | +$11.5K | 0.02% | 713 |
|
|
2021
Q3 | $221K | Sell |
1,196
-113
| -9% | -$20.9K | 0.01% | 737 |
|
|
2021
Q2 | $235K | Buy |
1,309
+25
| +2% | +$4.49K | 0.02% | 742 |
|
|
2021
Q1 | $215K | Sell |
1,284
-34
| -3% | -$5.69K | 0.02% | 750 |
|
|
2020
Q4 | $200K | Buy |
+1,318
| New | +$200K | 0.02% | 712 |
|
|
2018
Q4 | – | Sell |
-1,573
| Closed | -$201K | – | 664 |
|
|
2018
Q3 | $201K | Buy |
+1,573
| New | +$201K | 0.03% | 601 |
|
|
2018
Q1 | – | Sell |
-1,836
| Closed | -$256K | – | 604 |
|
|
2017
Q4 | $256K | Buy |
1,836
+17
| +0.9% | +$2.37K | 0.05% | 451 |
|
|
2017
Q3 | $213K | Sell |
1,819
-44
| -2% | -$5.15K | 0.04% | 445 |
|
|
2017
Q2 | $242K | Sell |
1,863
-127
| -6% | -$16.5K | 0.06% | 386 |
|
|
2017
Q1 | $269K | Buy |
1,990
+120
| +6% | +$16.2K | 0.07% | 344 |
|
|
2016
Q4 | $268K | Buy |
+1,870
| New | +$268K | 0.08% | 298 |
|
|
2016
Q1 | – | Sell |
-1,298
| Closed | -$203K | – | 415 |
|
|
2015
Q4 | $203K | Buy |
+1,298
| New | +$203K | 0.07% | 311 |
|